A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome

NCT04608110 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelodysplastic Syndrome (MDS)

Interventions

DRUG: ASTX030

Sponsor

Taiho Pharmaceutical Co., Ltd.